Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.250
+0.010 (0.81%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Milestone Pharmaceuticals Employees
Milestone Pharmaceuticals had 38 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
38
Change
n/a
Growth
n/a
Revenue / Employee
$46,947
Profits / Employee
-$1,799,026
Market Cap
168.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 38 | 0 | - |
| Dec 31, 2025 | 38 | 5 | 15.15% |
| Dec 31, 2024 | 33 | -14 | -29.79% |
| Dec 31, 2023 | 47 | 8 | 20.51% |
| Dec 31, 2022 | 39 | 10 | 34.48% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Innate Pharma | 164 |
| LENZ Therapeutics | 152 |
| Caribou Biosciences | 97 |
| Acumen Pharmaceuticals | 61 |
| Pyxis Oncology | 56 |
| OnKure Therapeutics | 45 |
| Corbus Pharmaceuticals Holdings | 36 |
MIST News
- 27 days ago - Milestone Pharmaceuticals Slides: Corporate presentation - Filings
- 5 weeks ago - Milestone Pharmaceuticals Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 6 weeks ago - Milestone Pharmaceuticals files $300M mixed securities shelf - TheFly
- 6 weeks ago - Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c - TheFly
- 6 weeks ago - Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Milestone Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Milestone Pharmaceuticals Earnings release: Q1 2026 - Filings